Press Release

/Press Release

Joint Press Announcement: RPS Diagnostics partners with Atomo Diagnostics

RPS Diagnostics partners with Atomo Diagnostics to develop next generation FebriDx blood tests for antibiotic stewardship in the outpatient setting Sarasota, Florida and Sydney, Australia (February 20, 2018) – United [...]

February 20th, 2018|

Atomo Diagnostics and Access Bio partner to expand access to best-in-class HIV rapid testing in global markets

Sydney, Australia and Seoul, South Korea – 23 January 2018 | Atomo Diagnostics and Access Bio Inc. today announce a strategic partnership to leverage the respective strengths of both innovative [...]

January 23rd, 2018|

PRESS RELEASE: Expert Review Panel for Diagnostics approves Atomo HIV Self Test for procurement by Unitaid and the Global Fund

Sydney, Australia, 7 December 2017 | Atomo Diagnostics, the world leader in integrated point-of-care rapid diagnostic devices, announced today that its Atomo HIV Self Test has been confirmed as eligible [...]

December 6th, 2017|

PRESS RELEASE: CE Marking for world’s only integrated HIV Self-Test from Atomo Diagnostics gives access to safe, accurate and reliable self-testing

  SYDNEY, AUSTRALIA, October 10, 2017 – Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE [...]

October 10th, 2017|

Atomo Diagnostics’ HIV Self Test receives approval from Kenya Ministry of Health

Sydney, Australia, May 30, 2017| Multi-award winning medical device innovator Atomo Diagnostics today announced its pioneering HIV self test product has been approved for sale in Kenya. Following successful product [...]

May 30th, 2017|

Atomo Diagnostics receives further international financing

SYDNEY, Australia, 1 February  2017: Medical device innovator Atomo Diagnostics today announced it had received US$1 million (A$1.31 million, C$1.32 million) in financing from Grand Challenges Canada to support its continued [...]

February 1st, 2017|

NG Biotech To Unveil Next Generation Integrated hCG Rapid Diagnostic Blood Test, Developed In Conjunction With Atomo Diagnostics

Guipry, France and Sydney, Australia, 8 November 2016 - French biotechnology company, NG Biotech, and Australian medical device innovator, Atomo Diagnostics, announced today that they have developed the world’s first [...]

November 8th, 2016|

Atomo Diagnostics receives grant to develop new, innovative HIV self-test solution

Self-testing is increasingly recognized for its potential to revolutionize HIV diagnosis and reach at-risk individuals who do not know their HIV status. This has the potential to improve detection rates [...]

October 27th, 2016|

Atomo Diagnostics secures $4.5 million in funding from New York-based Global Health Investment Fund and former Macquarie Group CEO Allan Moss

SYDNEY, Australia 11 August 2016 | Medical device innovator Atomo Diagnostics today announced it had raised A$4.5 million in new equity funding from a number of professional investors including the [...]

August 11th, 2016|

Award-winning Australian rapid HIV test featured at global AIDS conference

SYDNEY Australia, 8 July 2016 | Medical device design and development company Atomo Diagnostics will showcase its rapid diagnostic tests solutions for detection of HIV infection at the 21st International [...]

July 8th, 2016|